Low Enrollment in Clinical Trials Continues

LISA SCHULMEISTER, MN, RN, ACNS-BC, OCN, FAAN
Monday, June 02, 2014
Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
It’s well recognized that clinical trials are essential to progress in the field of oncology. Historically, clinical trials were available only at major cancer centers, but currently are available to patients at a variety of sites, including many community hospitals and practices. So why then does enrollment of adults in oncology clinical trials remain so low? It’s estimated that fewer than 5% enroll.

To determine barriers to enrollment, Kenneth L. Kehl, MD, from the Brigham and Women's Hospital in Boston, MA, and his colleagues surveyed a group of patients three to six months after the diagnosis of lung cancer or colorectal cancer. When patients were unavailable for interview, family members or individuals close to the patient were interviewed. One of the key questions asked was if clinical trial participation was offered as a treatment option, and if so, by whom and when.

Of 7,887 patients, 1,114 (14.1%) reported discussing clinical trial participation prior to initiation of treatment. Discussion of clinical trials was more common among college-educated patients and among those with incomes greater than $60,000 per year. Older patients and those who were African American and Asian, and those with comorbidities reported fewer discussions about clinical trials.

Most of the 287 who enrolled in a clinical trial (92.7%) learned about the trial from their healthcare providers, as opposed to other information sources, such as an internet search.  The majority of patients who declined clinical trial participation (92.7%) also reported learning about clinical trials from their healthcare providers rather than from other information sources. The bottom line is that only 287 patients enrolled in a clinical trial, or 3.6% of all patients. Although this represented 25.8% of those who discussed clinical trials, we still have a long way to go in increasing clinical trial enrollment.


Reference
Kehl KL, Arora NK, Schrag D et al. Abstract 6509. Presented at: 2014 American Society of Clinical Oncology Annual Meeting; May 30-June 3, 2014; Chicago, IL.


Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN
 
Blog Info
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN is an oncology nursing consultant and editor-in-chief of Oncology Nursing News.
Author Bio
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN, is the Editor-in-Chief for OncLive Nursing. She is an oncology nursing consultant and adjunct assistant professor of nursing at Louisiana State Health Sciences Center in New Orleans, LA. She provides continuing nursing education to nurses across the Unites States, is active in several professional nursing organizations, and is intrigued by the many ways nurses use technology to communicate.
 
 
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Blogs
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2017
Intellisphere, LLC. All Rights Reserved.